SHARE YOUR STORY

In 2017, 80,000 people were denied a PCSK9 inhibitor by health plans. 

For some, these advanced cardiovascular therapies are a last resort to prevent a debilitating heart attack or stroke.  

If you’ve been denied access to a PCSK9 inhibitor, let us know below.  We’re looking for advocates who are willing to speak up.

 

Name *
Name